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Methods: We prospectively randomized 60 ASA I–III women into three groups: group B (n= 20)
who received PVB using plain bupivacaine 0.5% (control group), group K (n= 21) who received
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analgesia (PCA) device in the ﬁrst 24 h after surgery. Secondary outcomes included dose of fentanyl
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102 A.M. Omar et al.Results: The three groups were found to be similar in the cumulative dose of PCA fentanyl in the ﬁrst
24 h (P= 0.62). Theywere also similar in terms of doses of fentanyl used in PACU (P= 0.87), time to
ﬁrst dose of fentanyl requested (P= 0.57), and VAS pain scores at all time points (P> 0.05).
Conclusion: We concluded that addition of ketamine (0.5 mg kg1) or tramadol (1.5 mg kg1) to
bupivacaine 0.5% in PVB formodiﬁed radical mastectomy do not have any analgesia-enhancing effect.
ª 2011 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Previous studies showed that breast surgery patients receiv-
ing thoracic paravertebral block (TPVB) in addition to gen-
eral anesthesia or intravenous sedation, seem to have shorter
recovery times [1], require fewer analgesics [1,2], experience
less postoperative pain [2,3], and experience less postopera-
tive nausea and vomiting (PONV) [2,3] compared to patients
receiving general anesthesia without TPVB. The increasing
popularity of TPVB analgesia as an effective method of
intra- and postoperative pain relief for breast surgery [1]
warrants more research on combinations of local anesthetics
and adjunctive analgesics. Traditionally, perineural inﬁltra-
tion of intercostal nerves is associated with high and rapid
absorption of local anesthetic into the systemic circulation,
leading to high blood concentrations’ [4]. The addition of
adjuncts, such as morphine [5], clonidine [6], and neostig-
mine [7] has been shown to enhance the quality and dura-
tion of sensory neural blockade and decrease the dose of
local anesthetic and supplemental analgesia. Ketamine has
local-anesthetic-like effects [8] and has been extensively used
through epidural and caudal routes with variable results
[9–12]. Tramadol has also been used as an adjunctive anal-
gesic to local anesthetic in neuraxial and peripheral nerve
blocks [13–16]. There is very little research on the efﬁcacy
and tolerability of the addition of adjuncts in PVBs
[17,18]. The use of tramadol and ketamine as adjuncts in
TPVB has not yet been investigated.
Therefore, the objective of the present prospective, random-
ized, double-blind study was to examine if the addition
of ketamine or tramadol to bupivacaine in TPVB would
enhance postoperative analgesia after modiﬁed radical
mastectomy.2. Methods
After Local Ethics Committee approval, 60 ASA status I–III
female patients scheduled to undergo elective modiﬁed radical
mastectomy were enrolled after giving written consent. The
enrollment period lasted from April 2007 to July 2008 in King
Faisal Specialist Hospital and Research Center in Riyadh.
Exclusion criteria included bleeding disorders, contraindica-
tions to nonsteroidal anti-inﬂammatory drugs (NSAIDs), al-
lergy to amide-type local anesthetics, infection at the
thoracic paravertebral injection site, severe spine deformity,
pregnancy or breast-feeding, and severe obesity (body mass in-
dex >35 kg m2). At the preoperative visit, the patients were
instructed by one of the investigators how to use the visual
analogue scale (VAS; 0–10 point where 0 = no pain and
10 = worst imaginable pain) for measurement of pain and
how to use the patient-controlled analgesia (PCA) device. All
patients received midazolam premedication 5–10 mg PO 15–20 min before surgery and 1 mg granisetron IV as a prophylac-
tic anti-emetic. Clinical monitoring included electrocardiogra-
phy, pulse oximetry and non-invasive arterial blood pressure.
They were randomly divided into three equal groups using
computerized randomization tables. A pharmacist who was
not involved in the study prepared and released the blinded
study local anesthetic medication immediately before the oper-
ation. Group B (control group) received plain bupivacaine
0.5% 2 mg kg1 (max 150 mg), group K received bupivacaine
as group B plus ketamine 0.5 mg kg1 and group T received
bupivacaine as group B plus tramadol 1.5 mg kg1 (max
150 mg). Thoracic paravertebral blocks were applied inside
the operating room while in patients in sitting position at levels
of T1 (1/3 of the dose) and T4 (2/3 of the dose) by using 22 G
Touhy needle according to the approach described by Eason
and Wyatt [19] after local inﬁltration of the skin and subcuta-
neous tissue of entry site with lidocaine 1% 2–3 ml using 25 G
needle. Midazolam 1–2 mg IV was given if needed during the
block. All patients then received a general anesthetic without
testing the sensory level attained by the TPVB. Intravenous
induction was achieved by propofol 2–3 mg kg1 and fentanyl
2–3 mcg kg1. Endotracheal intubation was facilitated by IV
rocuronium 0.6 mg kg1. Anesthesia was maintained with
sevoﬂurane 2–3% and 40% oxygen in air to maintain normoc-
arbi as monitored by capnography. Heart rate (HR) and mean
arterial blood pressure (MBP) were maintained within ±20%
of the preoperative baseline by giving IV bolus doses of fenta-
nyl 1–2 lg kg1 if the MAP and heart rate increased more than
20% from the baseline for more than 5 min (where inadequate
paravertebral block was suspected). Ephedrine 5 mg was given
in IV increments as needed to treat hypotension. By the con-
clusion of surgery, rocuronium effect was antagonized by IV
neostigmine 50 mcg kg1 (max 5 mg) with glycopyrrolate
6 mcg kg1. After emerging from anesthesia, the patients were
transferred to the post-anesthesia care unit (PACU) for a 2-h
observation period. Analgesia in the PACU was provided by
fentanyl 0.25–0.50 mcg kg1 IV as a rescue medication, if
needed, every 10 min until pain VAS score was 63. Postoper-
ative patient controlled fentanyl analgesia (PCA) was used
according to the hospital protocol (20 mcg per bolus dose with
a 6-min delay). All patients were given oral acetaminophen 1 g
three times daily and ibuprofen 400–600 mg three times daily
PO in the surgical ward. Pain intensity on the VAS (0–10)
was assessed by nurse staff who were blinded to group alloca-
tion at the following times: on admission to PACU, 1 h later,
on discharge from the PACU, 4-, 8-, 12-, 18-, and 24-h postop-
eratively. Incidence of postoperative nausea and vomiting was
reported. Metoclopramide (10 mg IV) was given 8-hourly as
needed. Time to ﬁrst using the fentanyl PCA analgesia was
recorded and total dose of PCA fentanyl was calculated.
Any psychomimetic change (deﬁned as agitation, hallucina-
tions, or vivid dreams) which happened in the PACU or the
surgical ward was reported. The patients and the investigators
Table 2 Doses of fentanyl used by patients in PACU and
cumulative PCA dose in the ﬁrst 24 h postoperative. Data are
median (range).
Fentanyl dose
(mcg)
Group B
(n= 20)
Group K
(n= 21)
Group T
(n= 19)
P value
PACU 0 (0–180) 0 (0–200) 0 (0–200) 0.87
24-h PCA 190 (120–620) 200 (120–700) 180 (120–380) 0.62
PACU, postanesthesia care unit; PCA, patient-controlled analgesia;
group B, bupivacaine; group K, ketamine; group T, tramadol.
Table 3 Pain visual analogue score. Data are median (range).
Time Group B
(n= 20)
Group K
(n= 21)
Group T
(n= 19)
P value
On admission to PACU 1 (0–3) 1 (0–3) 1 (0–3) 0.91
1 h later 1 (0–5) 1 (0–2) 1 (0–5) 0.17
On discharge from PACU 1 (0–3) 2 (0–3) 1 (0–3) 0.08
4-h postoperative 1 (0–4) 1 (0–4) 1 (0–3) 0.88
8-h postoperative 2 (0–5) 2 (0–3) 1 (0–6) 0.19
12-h postoperative 1 (0–3) 1 (0–3) 1 (0–3) 0.96
18-h postoperative 2 (0–5) 2 (1–5) 2 (0–5) 0.91
24-h postoperative 1.5 (0–5) 1 (0–3) 2 (0–3) 0.78
PACU, postanesthesia care unit; group B, bupivacaine; group K,
ketamine; group T, tramadol.
Table 4 Complications occurred after block and dose of
ephedrine. Data are number (percentage) or median (range).
Variable Group B
(n= 20)
Group K
(n= 21)
Group T
(n= 19)
P value
Hypotension 3 (15) 3 (14) 4 (21) 0.91
Dose of ephedrine 0 (0–15) 0 (1–15) 0 (0–10) 0.49
PONV 6 (30) 8 (38) 6 (29) 0.84
Antiemetic use 5 (20) 4 (19) 5 (26) 0.66
Psychomimetic changes 0 (0) 4 (19)* 0 (0) 0.02
PONV, postoperative nausea or vomiting; group B, bupivacaine;
group K, ketamine; group T, tramadol.
* Signiﬁcant compared to group B and group T.
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composition of the study mixture.
The primary outcome of the study was consumption of
PCA fentanyl. From our previous work, we found that pa-
tients undergoing breast surgery under combined general anes-
thesia and PVB required 207 ± 51 mcg (mean ± SD) of
fentanyl through PCA in the day of surgery (data not pub-
lished). We assumed that a 30% difference of fentanyl con-
sumption would be clinically signiﬁcant between groups. A
sample size was calculated to be 18 cases for each group to give
a power of 90% at a level of 5% signiﬁcance. We enrolled 20
cases per group to accommodate for dropouts. Secondary out-
comes included probability of post-block hypotension, need
for ephedrine use, postoperative pain VAS score, dose of fen-
tanyl in PACU, occurrence of psychomimetic changes and
incidence of PONV.
Statistical analyses were performed using the SPSS for Win-
dows, version 15 (SPSS Inc., Chicago, IL). Data were ﬁrst
tested for normality by Klomogorov–Smirnov test. Normally
distributed continuous data were analyzed by using one-way
analysis of variance (ANOVA). Non-normally distributed con-
tinuous and ordinal data were analyzed using Kruskall–Wallis
test. Categorical data was analyzed by Chi-square or Fisher’s
exact test as appropriate. The results are presented as
mean ± SD, median (range), or number of patients as appro-
priate. A P value <0.05 was considered statistically signiﬁcant.
3. Results
One hundred and twenty-seven patients were found eligible for
the study. Forty-one patients met our exclusion criteria and 26
refused participation. Sixty patients were randomized for three
groups: group B (n= 20), group K (n= 21), and group T
(n= 19). No patient was excluded from the study.
The three groups were found to be similar in terms of age,
body mass index, ASA classiﬁcation and duration of surgery
and anesthesia (Table 1). Two patients in group B, two pa-
tients in group K, and one patient in group T showed evidence
of block failure (increased blood pressure and heart rate in re-
sponse to surgical stimulation). Those ﬁve patients needed fre-
quent boluses of IV fentanyl to achieve analgesia
intraoperatively and in PACU.
The fentanyl dose needed in the PACU and the cumulative
fentanyl PCA dose in the day of surgery were similar between
the three groups (Table 2). The time interval (h) to request
postoperative analgesia [median (range)] was also similar
between the three groups [group B 14.5 (0.25–21), group K
14.5 (0.5–18), and group T 13.5 (0.25–19), P= 0.57].Table 1 Patient and procedure characteristics. Data are mean
(SD) or median (range).
Variable Group B
(n= 20)
Group K
(n= 21)
Group T
(n= 19)
Age (years) 49.3 (10.5) 48.2 (8.6) 47.5 (9.3)
Body mass index (kg m2) 29 (2.5) 27.7 (3.2) 27.7 (2.6)
ASA (I/II/III) 4/12/4 5/10/6 4/11/4
Duration of surgery (min) 92.6 (10.7) 93 (8.7) 92.2 (10.1)
Duration of anesthesia (min) 116.6 (11.5) 115.5 (9.6) 118.2 (9.6)
Group B, bupivacaine; group K, ketamine; group T, tramadol.There were no statistically signiﬁcant differences in pain
scores between groups at any of the determined eight time
points (Table 3).
Untoward effects including episodes of intraoperative
hypotension occurring after the PVB, ephedrine use, postoper-
ative nausea and vomiting and antiemetic use were similar in
the three groups (Table 4). Four patients in group K showed
psychomimetic changes (2 hallucinations and 2 unpleasant
dreams). No patient in the study showed any evidence of
pneumothorax.
4. Discussion
The major ﬁning of this study was the lack of any analgesia-
enhancing effect of ketamine or tramadol added to bupiva-
caine 0.5% TPVB in females undergoing modiﬁed radical
mastectomy.
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for regional block have been studied in order to overcome the
disadvantages of local anesthetic solutions alone, such as short
duration of action and systemic toxicity. To our knowledge, no
previous study has investigated the role of ketamine or trama-
dol as adjuncts to local anesthetics in PVB.
The use of ketamine as an adjunct to local anesthetic has
been extensively investigated in epidural route with favorable
results [9,11–13] but much less in peripheral nerve blocks with
variable results [20,21]. The reason that made the investigators
try ketamine as an adjunct to local anesthetics in neuraxial or
peripheral nerve blocks is the local anesthetic-like action that
ketamine has. Wagner et al. found that ketamine could interact
with sodium channel of rat myocyte in a local anesthetic-like
fashion [22]. Adding to this effect is the ability of ketamine to
block N-methyl-D-aspartate receptors which are thought to be
found all over the human body nervous system playing a cen-
tral role in nociception [23]. Weber et al. [24] studied the effect
of ketamine on frog nerve conduction and also reported that
subcutaneous inﬁltration of ketamine 0.5% caused loss of pain-
ful and thermal sensation in volunteers but the ﬁrst study that
investigated the role of ketamine as an adjunct to local anes-
thetic in peripheral nerve block has been released in 2002 [20].
In this study, Lee et al. have investigated the sensory and motor
effects of ketamine when added to ropivacaine 0.5% in inter-
scalene block. Similar to our results, they did not ﬁnd any sen-
sory or motor prolonging effect of ketamine. Again they
reported 44% incidence of psychomimetic side effects in pa-
tients who had received ketamine/ropivacaine in comparison
to 5% in those patients who had received ropivacaine alone.
We assume three explanations for the lack of postoperative opi-
oid-sparing effect of ketamine in PVB. The ﬁrst two explana-
tions were underscored by Lee et al. in their study [20]. They
stated that the low concentration of ketamine in their study
(0.1%) might not be enough to exert its local anesthetic action.
They also assumed that the ability of ketamine to exert local
antinociception effect is only effective when there is an inﬂam-
matory process at the site of injection which is not the case in
their or our study. The third explanation we assume is the avail-
ability of ketamine at the site of injection. The dose of ketamine
we have used (0.5 mg kg1) might have been absorbed quickly
in the systemic circulation and any local anesthetic effect could
have been masked specially with the long-acting local anes-
thetic we used (bupivacaine). This also might have happened
in the study of Lee et al. as they injected their study solution
in the interscalene area which is vessel-rich. The relatively high
incidence of ketamine-related psychomimetic adverse effects in
both studies may support this explanation. This also can ex-
plain the good analgesia enhancing effect and the lack of psyc-
homimetic effects of ketamine when given in the epidural or
caudal route where the systemic absorption is slow.
Tramadol is an analgesic drug that acts at central and
peripheral l-opioid and monoaminergic receptors [25]. Its lo-
cal anesthetic effects and lack of irreversible nerve toxicity
have been shown in an animal study [26]. Tramadol has also
some afﬁnity to peripheral a-2 receptors which may explain
its analgesic effect when given in the vicinity of peripheral
nerves [27]. Tramadol was found to be as effective as lidocaine
when injected subcutaneously in patients undergoing superﬁ-
cial minor procedures [28]. As the case with ketamine, trama-
dol has been shown to be a useful adjunct to local anesthetics
when given neuraxially [13,14,16] but its analgesia-enhancingeffect is very variable when used in peripheral nerve blocks.
Some studies showed a beneﬁcial effect [29–31] and others
showed no beneﬁt [32,33].
Our results are similar to the results of previous two studies
which use tramadol as adjuncts to local anesthetics [32,33]. In
the ﬁrst study, Mannion et al. [32] added tramadol 1.5 mg kg1
to levobupivacaine 0.5% (0.4 ml kg1) in psoas compartment
block for patients undergoing primary total hip or knee
replacement and they did not ﬁnd any beneﬁt in comparison
to plain levobupivacaine. In the other study, Kesimci et al.
[33] added tramadol 100 mg to ropivacaine 0.75% in axillary
brachial plexus block for patients undergoing hand or forearm
surgery and they did not ﬁnd any analgesia-enhancing effect
for tramadol in comparison to plain ropivacaine.
On the other hand, three studies showed a beneﬁcial effect
for tramadol as an adjunct to local anesthetics. In the ﬁrst
study, Kapral et al. [29] demonstrated that the addition of
tramadol 100 mg to mepivacaine 1% for axillary brachial
plexus block signiﬁcantly prolonged sensory and motor block
compared with plain mepivacaine or axillary block with intra-
venous tramadol. In the second study, Robaux et al. [30], stud-
ied the effect of addition of 3 different doses of tramadol (40,
100 and 200 mg) to mepivacaine 1.5% in axillary brachial
plexus block. They found that addition of tramadol enhances
in a dose-dependent manner the duration of postoperative
analgesia compared to plain mepivacaine. In the third study,
Kaabachi et al. [31] found that the addition of tramadol (100
or 200 mg) to lidocaine 1.5% for axillary brachial plexus block
signiﬁcantly prolonged postoperative pain-free periods com-
pared to plain lidocaine.
Comparison of these studies is difﬁcult because of the ver-
satility of the used local anesthetics, dose of tramadol, type of
surgery, and the site of nerve blocks. We observe in these dif-
ferent studies that tramadol always shows its analgesia-
enhancing effect when combined with short-acting local anes-
thetics (mepivacaine and lidocaine) but not with long-acting
local anesthetics (levobupivacaine and ropivacaine). That
may explain the lack of its favorable effect in our study as
we used the long-acting local anesthetic bupivacaine which
may have masked a possible analgesic effect of tramadol. All
the beneﬁcial effects of tramadol have been shown in axillary
brachial plexus block. A difference in neural structure between
these peripheral nerves and the more central spinal nerves in
PVB may explain the susceptibility to the local-anesthetic ef-
fect of tramadol. The dose of tramadol we added (1.5 mg kg1)
may not be high enough to exert any analgesic effect. We could
not use a higher dose of tramadol (200 mg) as in some previous
studies [31] because of the possibility of epidural and intrathe-
cal injections in PVB.
Hypotension that occurred after the PVB in about 20% of
patients can be explained by unilateral sympathectomy that
may follow instillation of local anesthetics near the thoracic
sympathetic ganglia [34]. Use of prophylactic antiemetic (gra-
nisetron) and induction of general anesthesia with propofol
may decrease the incidence of PONV in all patients. Use of
prophylactic antiemetic in this type of surgery is recommended
due to the high incidence of PONV [35].
We conclude that addition of ketamine (0.5 mg kg1) or
tramadol (1.5 mg kg1) to bupivacaine 0.5% in PVB for fe-
male patients undergoing modiﬁed radical mastectomy does
not have any analgesia-enhancing effect in the postoperative
period as regards to VAS or 24-h fentanyl consumption. On
Role of ketamine and tramadol as adjuncts to bupivacaine 105the contrary, ketamine addition causes a harmful effect by pro-
ducing psychomimetic changes.References
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